| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/17/2013 | CN102416182B Application of micro ribose nucleic acid (RNA) (miR)-574-5p |
| 04/17/2013 | CN102335440B Two gene vaccines containing different CpG (cytidine-phosphatte-guanonine) sequences PCV2 (porcine circovirus 2)-ORF2 and preparation process thereof |
| 04/17/2013 | CN102250239B Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof |
| 04/17/2013 | CN102250234B Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof |
| 04/17/2013 | CN102145177B Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 04/17/2013 | CN102002483B Hematopoietic targeted helper adenovirus and application thereof |
| 04/17/2013 | CN101984056B RNA interference target RNA of long non-coding RNA related to human melanoma cells and application thereof |
| 04/17/2013 | CN101851631B Codon-optimized EV71 VP1 gene and nucleic acid vaccine |
| 04/17/2013 | CN101586167B Diagnosis reagent for primary hepatocellular carcinoma, reagent kit and prevention and cure medicaments |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/16/2013 | US8420800 Head-and-neck tumor proliferation inhibitor |
| 04/16/2013 | US8420799 Therapeutic compositions |
| 04/16/2013 | US8420619 Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein |
| 04/16/2013 | US8420618 MicroRNA-based method for anti-colorectal cancer effects and prognosis of colorectal cancer |
| 04/16/2013 | US8420615 Immunostimulatory oligonucleotide multimers |
| 04/16/2013 | US8420613 Methods and compositions for reducing amyloid beta levels |
| 04/16/2013 | US8420612 Diabetes treatment methods and drug targets therefor |
| 04/16/2013 | US8420611 brain cancer treatment with a mixture of a viral vector and ganciclovir; delivered to target cells; provide prolong survival |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420395 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 04/16/2013 | US8420391 RNA sequence-specific mediators of RNA interference |
| 04/16/2013 | US8420388 Gene of porcine beta casein, a promoter of the same and the use thereof |
| 04/16/2013 | US8420386 Transposon-based targeting system |
| 04/16/2013 | US8420372 Porcine adeno-associated viruses |
| 04/16/2013 | US8420350 Glycosylation-deficient hepatocyte growth factor |
| 04/16/2013 | US8420071 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2488821C Methods and compositions for grafting functional loops into a protein |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2419284C Prna chimera |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/11/2013 | WO2013052965A2 Control of whole body energy homeostasis by microrna regulation |
| 04/11/2013 | WO2013052523A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 04/11/2013 | WO2013052507A1 TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS |
| 04/11/2013 | WO2013052158A2 Targeted nanovectors and their use for treatment of brain tumors |
| 04/11/2013 | WO2013051900A2 Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof |
| 04/11/2013 | WO2013051459A1 Promoter capable of promoting inhibition of expression of mrna by rna interference, and use thereof |
| 04/11/2013 | WO2013051435A1 Therapeutic agent, gene therapy agent, and method for preventing invasion of eosinophil |
| 04/11/2013 | WO2013012811A3 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 04/11/2013 | WO2013010176A3 Pharmacophores for amyloid fibers involved in alzheimer's disease |
| 04/11/2013 | WO2013003801A3 Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction |
| 04/11/2013 | WO2012170911A3 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 04/11/2013 | WO2012170776A3 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
| 04/11/2013 | WO2012153193A3 Protein-active agent conjugates and method for preparing the same |
| 04/11/2013 | US20130090669 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 04/11/2013 | US20130090465 ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS |
| 04/11/2013 | US20130090376 Antibodies to tumor associated proteins |
| 04/11/2013 | US20130090374 Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis |
| 04/11/2013 | US20130090263 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 04/11/2013 | CA2851223A1 Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof |
| 04/11/2013 | CA2850624A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 04/10/2013 | EP2578685A2 RNA containing modified nucleosides and methods of use thereof |
| 04/10/2013 | EP2578603A1 B cell activating factor antagonist and preparation method and use thereof |
| 04/10/2013 | EP2578236A1 PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT |
| 04/10/2013 | EP2576784A2 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
| 04/10/2013 | EP2576783A2 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 04/10/2013 | EP2575895A2 Novel amino alcohol cationic lipids for oligonucleotide delivery |
| 04/10/2013 | EP2575894A1 Delivery of lentiviral vectors to the brain |
| 04/10/2013 | EP2575860A1 Diagnostic, screening and therapeutic applications of ocab-based tools |
| 04/10/2013 | EP2575764A2 Biodegradable lipids for the delivery of active agents |
| 04/10/2013 | CN103037905A Vectors and sequences for the treatment of diseases |
| 04/10/2013 | CN103037890A Dendritic cell inhibitory proteins from ticks |
| 04/10/2013 | CN103037840A Lipid membrane structure with nuclear transferability |
| 04/10/2013 | CN103031337A Small nucleic acid molecule delivery technology |
| 04/10/2013 | CN103031334A Dual-target siRNA eukaryotic expression plasmid capable of inhibiting STAT3 and AFP gene expression, and application of expression plasmid |
| 04/10/2013 | CN103030688A Short chain polypeptide for inhibiting cancer cell growth as well as encoding gene and application of short chain polypeptide |
| 04/10/2013 | CN103028122A Application of miR-214 to preparation of product for preventing or treating alzheimer disease |
| 04/10/2013 | CN103028121A miR-21 compound of target microglial cell and preparation method and application of miR-21 compound |
| 04/10/2013 | CN103028120A Compositions and methods for the diagnosis and therapy of BCL2-associated cancers |
| 04/10/2013 | CN103028119A Application of miR-132 in preparation of drug for treating parkinsonism |
| 04/10/2013 | CN103028111A Eimeria acevulina immunity adjustment type polyvalent multi-epitope DNA (Deoxyribose Nucleic Acid) vaccine |
| 04/10/2013 | CN102408472B Bt (Bacillus Thuringiensis) protein Cry62Aa1 and coding gene as well as application thereof |
| 04/10/2013 | CN102321638B New porcine reproductive and respiratory syndrome virus ORF5 modified gene and application thereof |
| 04/10/2013 | CN102260356B Chitosan derivative used as gene vector, and preparation method and application thereof |
| 04/10/2013 | CN102140469B Human miR (microRNA)-1233 antisensenucleic acid and application thereof |
| 04/10/2013 | CN102086266B Polypeptide-containing asymmetric hyperbranched amphoteric polyelectrolyte and preparation method thereof |
| 04/10/2013 | CN102078621B Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 04/10/2013 | CN102002493B Application of small RNA-326 in preparation of medicament |
| 04/10/2013 | CN101967186B Encephalitis virus protein and code gene and application thereof |
| 04/10/2013 | CN101967185B Encephalitis virus protein as well as coding gene and application thereof |
| 04/10/2013 | CN101899443B Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof |
| 04/10/2013 | CN101775375B Preparation method of recombinant adeno-associated viruses containing EB virus latent membrane protein 1 and 2 genes and application thereof |
| 04/10/2013 | CN101732731B Lentiviral vector-mediated gene transfer and uses thereof |
| 04/09/2013 | US8415525 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2013 | US8415461 Amphiphilic substances and functionalized lipid vesicles including the same |
| 04/09/2013 | US8415323 MicroRNAs for inhibiting viral replication |
| 04/09/2013 | US8415320 Delivery of dsRNA to arthropods |
| 04/09/2013 | US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8415316 Method for increasing bone mass |
| 04/09/2013 | US8415315 Methods and compositions for inhibiting the proliferation of cancer cells |
| 04/09/2013 | US8415314 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 04/09/2013 | US8415313 Antisense oligomers and methods for inducing immune tolerance and immunosuppression |
| 04/09/2013 | US8415303 Method of treatment using a soluble human delta protein fragment |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414884 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
| 04/09/2013 | US8414883 Parvovirus cancer therapy and combination with chemotherapy |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2360549C Double nuclear transfer method and results thereof |
| 04/09/2013 | CA2274319C Methods and compositions for polypeptide engineering |